CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) shares in Thousands, $ in Thousands |
Total |
Common Stock |
Treasury Stock |
Paid-in Capital |
Accumulated Other Comprehensive Loss, net of tax |
Retained Deficit |
| Beginning balance (in shares) at Dec. 29, 2024 |
|
|
22,050
|
|
|
|
|
| Beginning balance at Dec. 29, 2024 |
|
$ (84,269)
|
$ 22
|
$ (164,937)
|
$ 233,667
|
$ (62)
|
$ (152,959)
|
| Beginning balance (in shares) at Dec. 29, 2024 |
|
|
|
4,647
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
|
(335)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
|
241
|
|
$ 11,993
|
(11,752)
|
|
|
| Non-cash stock compensation |
|
2,365
|
|
|
2,365
|
|
|
| Net income (loss) |
|
1,249
|
|
|
|
|
1,249
|
| Other comprehensive income (loss) |
|
2
|
|
|
|
2
|
|
| Ending balance (in shares) at Apr. 20, 2025 |
|
|
22,050
|
|
|
|
|
| Ending balance at Apr. 20, 2025 |
|
(80,412)
|
$ 22
|
$ (152,944)
|
224,280
|
(60)
|
(151,710)
|
| Ending balance (in shares) at Apr. 20, 2025 |
|
|
|
4,312
|
|
|
|
| Beginning balance (in shares) at Dec. 29, 2024 |
|
|
22,050
|
|
|
|
|
| Beginning balance at Dec. 29, 2024 |
|
(84,269)
|
$ 22
|
$ (164,937)
|
233,667
|
(62)
|
(152,959)
|
| Beginning balance (in shares) at Dec. 29, 2024 |
|
|
|
4,647
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income (loss) |
|
(13,177)
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
2
|
|
|
|
|
|
| Ending balance (in shares) at Oct. 05, 2025 |
|
|
22,050
|
|
|
|
|
| Ending balance at Oct. 05, 2025 |
|
(96,090)
|
$ 22
|
$ (144,772)
|
214,856
|
(60)
|
(166,136)
|
| Ending balance (in shares) at Oct. 05, 2025 |
|
|
|
4,084
|
|
|
|
| Beginning balance (in shares) at Apr. 20, 2025 |
|
|
22,050
|
|
|
|
|
| Beginning balance at Apr. 20, 2025 |
|
(80,412)
|
$ 22
|
$ (152,944)
|
224,280
|
(60)
|
(151,710)
|
| Beginning balance (in shares) at Apr. 20, 2025 |
|
|
|
4,312
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
|
(148)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
|
230
|
|
$ 5,299
|
(5,069)
|
|
|
| Non-cash stock compensation |
|
(2,454)
|
|
|
(2,454)
|
|
|
| Net income (loss) |
|
3,993
|
|
|
|
|
3,993
|
| Ending balance (in shares) at Jul. 13, 2025 |
|
|
22,050
|
|
|
|
|
| Ending balance at Jul. 13, 2025 |
|
(78,643)
|
$ 22
|
$ (147,645)
|
216,757
|
(60)
|
(147,717)
|
| Ending balance (in shares) at Jul. 13, 2025 |
|
|
|
4,164
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
|
(80)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
|
|
|
$ 2,873
|
(2,873)
|
|
|
| Non-cash stock compensation |
|
972
|
|
|
972
|
|
|
| Net income (loss) |
|
(18,419)
|
|
|
|
|
(18,419)
|
| Other comprehensive income (loss) |
|
0
|
|
|
|
|
|
| Ending balance (in shares) at Oct. 05, 2025 |
|
|
22,050
|
|
|
|
|
| Ending balance at Oct. 05, 2025 |
|
$ (96,090)
|
$ 22
|
$ (144,772)
|
214,856
|
(60)
|
(166,136)
|
| Ending balance (in shares) at Oct. 05, 2025 |
|
|
|
4,084
|
|
|
|
| Beginning balance (in shares) at Dec. 28, 2025 |
|
18,009
|
22,050
|
|
|
|
|
| Beginning balance at Dec. 28, 2025 |
|
$ (106,348)
|
$ 22
|
$ (143,247)
|
213,180
|
(60)
|
(176,243)
|
| Beginning balance (in shares) at Dec. 28, 2025 |
|
4,041
|
|
4,041
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
|
(243)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
|
$ 26
|
|
$ 8,674
|
(8,648)
|
|
|
| Non-cash stock compensation |
|
1,366
|
|
|
1,366
|
|
|
| Net income (loss) |
|
(2,178)
|
|
|
|
|
(2,178)
|
| Equity issuance costs |
[1] |
479
|
|
|
479
|
|
|
| Ending balance (in shares) at Apr. 19, 2026 |
|
|
22,050
|
|
|
|
|
| Ending balance at Apr. 19, 2026 |
|
$ (106,655)
|
$ 22
|
$ (134,573)
|
206,377
|
(60)
|
(178,421)
|
| Ending balance (in shares) at Apr. 19, 2026 |
|
|
|
3,798
|
|
|
|
| Beginning balance (in shares) at Dec. 28, 2025 |
|
18,009
|
22,050
|
|
|
|
|
| Beginning balance at Dec. 28, 2025 |
|
$ (106,348)
|
$ 22
|
$ (143,247)
|
213,180
|
(60)
|
(176,243)
|
| Beginning balance (in shares) at Dec. 28, 2025 |
|
4,041
|
|
4,041
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income (loss) |
|
$ (22,979)
|
|
|
|
|
|
| Other comprehensive income (loss) |
|
$ (2)
|
|
|
|
|
|
| Ending balance (in shares) at Oct. 04, 2026 |
|
18,930
|
22,050
|
|
|
|
|
| Ending balance at Oct. 04, 2026 |
|
$ (126,213)
|
$ 22
|
$ (110,332)
|
183,381
|
(62)
|
(199,222)
|
| Ending balance (in shares) at Oct. 04, 2026 |
|
3,120
|
|
3,120
|
|
|
|
| Beginning balance (in shares) at Apr. 19, 2026 |
|
|
22,050
|
|
|
|
|
| Beginning balance at Apr. 19, 2026 |
|
$ (106,655)
|
$ 22
|
$ (134,573)
|
206,377
|
(60)
|
(178,421)
|
| Beginning balance (in shares) at Apr. 19, 2026 |
|
|
|
3,798
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
|
(636)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
|
186
|
|
$ 22,761
|
(22,575)
|
|
|
| Non-cash stock compensation |
|
495
|
|
|
495
|
|
|
| Net income (loss) |
|
386
|
|
|
|
|
386
|
| Other comprehensive income (loss) |
|
(2)
|
|
|
|
(2)
|
|
| Ending balance (in shares) at Jul. 12, 2026 |
|
|
22,050
|
|
|
|
|
| Ending balance at Jul. 12, 2026 |
|
(105,590)
|
$ 22
|
$ (111,812)
|
184,297
|
(62)
|
(178,035)
|
| Ending balance (in shares) at Jul. 12, 2026 |
|
|
|
3,162
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares) |
|
|
|
(42)
|
|
|
|
| Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan |
|
(120)
|
|
$ 1,480
|
(1,600)
|
|
|
| Non-cash stock compensation |
|
684
|
|
|
684
|
|
|
| Net income (loss) |
|
(21,187)
|
|
|
|
|
(21,187)
|
| Other comprehensive income (loss) |
|
$ 0
|
|
|
|
|
|
| Ending balance (in shares) at Oct. 04, 2026 |
|
18,930
|
22,050
|
|
|
|
|
| Ending balance at Oct. 04, 2026 |
|
$ (126,213)
|
$ 22
|
$ (110,332)
|
$ 183,381
|
$ (62)
|
$ (199,222)
|
| Ending balance (in shares) at Oct. 04, 2026 |
|
3,120
|
|
3,120
|
|
|
|
|
|